U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 3Cl.La.7H2O
Molecular Weight 371.371
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LANTHANUM CHLORIDE HEPTAHYDRATE

SMILES

O.O.O.O.O.O.O.[Cl-].[Cl-].[Cl-].[La+3]

InChI

InChIKey=FDFPDGIMPRFRJP-UHFFFAOYSA-K
InChI=1S/3ClH.La.7H2O/h3*1H;;7*1H2/q;;;+3;;;;;;;/p-3

HIDE SMILES / InChI

Molecular Formula La
Molecular Weight 138.9055
Charge 3
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Lanthanum hydroxide (La(OH)3) is a rare novel earth compound which has so far been fabricated with various morphologies such as nanopowders, nanotubes, nanowires, nanorods and nanobelts from different methods like solvothermal, hydrothermal, sol-gel and template assisted routes. This compound has many attractive applications in gas-exhaust convectors, optical coatings, catalysts, superconductors, hydrogen storage materials and next generation of high dielectric constant gate dielectrics. It is a useful carrier precipitate for a number of ions. It was applied to the collection of traces of aluminum, bismuth, gold, iridium, iron, lead, thallium and titanium in silver metal. It is a predecessor Lanthanum oxide, which has a great interest as catalyst material.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
FOSRENOL

Approved Use

FOSRENOL is a phosphate binder indicated to reduce serum phosphate in patients with end stage renal disease (ESRD).

Launch Date

2004
PubMed

PubMed

TitleDatePubMed
A confusional state associated with use of lanthanum carbonate in a dialysis patient: a case report.
2009 Oct
Patents
Substance Class Chemical
Created
by admin
on Sat Dec 16 08:01:23 GMT 2023
Edited
by admin
on Sat Dec 16 08:01:23 GMT 2023
Record UNII
936G1MX96X
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LANTHANUM CHLORIDE HEPTAHYDRATE
MI  
Systematic Name English
LANTHANUM CHLORIDE (LACL3), HEPTAHYDRATE
Common Name English
LANTHANUM TRICHLORIDE HEPTAHYDRATE
Systematic Name English
LANTHANUM CHLORIDE HEPTAHYDRATE [MI]
Common Name English
LANTHANUM(III) CHLORIDE HEPTAHYDRATE
Systematic Name English
Code System Code Type Description
CAS
10025-84-0
Created by admin on Sat Dec 16 08:01:23 GMT 2023 , Edited by admin on Sat Dec 16 08:01:23 GMT 2023
PRIMARY
PUBCHEM
165791
Created by admin on Sat Dec 16 08:01:23 GMT 2023 , Edited by admin on Sat Dec 16 08:01:23 GMT 2023
PRIMARY
EPA CompTox
DTXSID90905297
Created by admin on Sat Dec 16 08:01:23 GMT 2023 , Edited by admin on Sat Dec 16 08:01:23 GMT 2023
PRIMARY
MERCK INDEX
m6684
Created by admin on Sat Dec 16 08:01:23 GMT 2023 , Edited by admin on Sat Dec 16 08:01:23 GMT 2023
PRIMARY
FDA UNII
936G1MX96X
Created by admin on Sat Dec 16 08:01:23 GMT 2023 , Edited by admin on Sat Dec 16 08:01:23 GMT 2023
PRIMARY
Related Record Type Details
ANHYDROUS->SOLVATE